Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
98.300,86
-0,38%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Carisma Therapeutics Inc (CARM) Carisma Therapeutics Inc (CARM) Notizie

Carisma Therapeutics Inc

CARM
0,399
0,011 (2,84%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/12/202414:35EDGAR2Form 8-K - Current report
09/12/202414:30PRNUSCarisma Therapeutics Announces Strategic Restructuring to..
05/12/202417:45BWCARMILA: Information concerning the total number of voting..
27/11/202413:30PRNUSCarisma Therapeutics to Participate in the 7th Annual..
17/11/202413:30PRNUSCarisma Therapeutics Presents Promising New Preclinical Data..
08/11/202413:30PRNUSCarisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In..
07/11/202413:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:35EDGAR2Form 8-K - Current report
07/11/202413:30PRNUSCarisma Therapeutics Reports Third Quarter 2024 Financial..
06/11/202417:45BWCARMILA : Informations relatives au nombre total de droits..
05/11/202415:05PRNUSCarisma Therapeutics to Present New Data on Anti-GPC3 In..
01/11/202421:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202421:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/10/202421:30EDGAR2Form 8-K - Current report
30/10/202421:30PRNUSCarisma Therapeutics Announces Changes to its Board of..
17/10/202417:45BWCarmila: Third-quarter 2024 Financial Information
16/10/202415:54BWCARMILA : COMMUNIQUÉ DE PRESSE EN DATE DU 16 OCTOBRE 2024
11/10/202422:49EDGAR2Form 8-K - Current report
04/10/202415:05PRNUSCarisma Therapeutics Announces Upcoming Presentations at..
02/10/202417:45BWCarmila : Informations relatives au nombre total de droits..
25/9/202412:25BWCARMILA : COMMUNIQUÉ DE PRESSE EN DATE DU 25 SEPTEMBRE 2024
24/9/202418:26BWCARMILA : COMMUNIQUÉ DE PRESSE EN DATE DU 24 SEPTEMBRE 2024
24/9/202418:10BWSuccessful Completion of Tender Offer on Carmila’s Bonds..
17/9/202418:30BWSUCCES DE L’EMISSION INAUGURALE D’UN « GREEN BOND » DE 300..
16/9/202410:47BWCARMILA ANNONCE LE LANCEMENT D'UNE OFFRE DE RACHAT SUR SES..
10/9/202413:30PRNUSCarisma and Moderna Expand Collaboration to Develop Two In..
09/9/202417:45BWCarmila: Information Concerning the Total Number of Voting..
06/9/202416:07BWCARMILA : COMMUNIQUÉ DE PRESSE DU 6 SEPTEMBRE 2024
03/9/202413:30PRNUSCarisma Therapeutics to Present at Upcoming Conferences
19/8/202417:45BWCARMILA : Informations relatives au nombre total de droits..
08/8/202413:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:37EDGAR2Form 8-K - Current report
08/8/202413:30PRNUSCarisma Therapeutics Reports Second Quarter 2024 Financial..
06/8/202413:30PRNUSCarisma Therapeutics Announces Expansion of Its Scientific..
25/7/202419:29BWCarmila : Finalisation de l’acquisition d’un bloc de 7% de..
24/7/202419:56BWCarmila: Launch of a Share Buyback Program for €10 Million
24/7/202419:38BWCarmila: 2024 Half-Year Financial Report Available
24/7/202417:49BWCarmila : Résultats du premier semestre 2024
09/7/202413:30EDGAR2Form 8-K - Current report
05/7/202418:11BWCarmila: Resources Devoted to the Liquidity Contract as of..
02/7/202417:45BWCARMILA: Information Concerning the Total Number of Voting..
01/7/202418:48BWCarmila : Finalisation de l’acquisition de Galimmo SCA
01/7/202413:30PRNUSCarisma Therapeutics Announces Changes to its Board of..
01/7/202407:00BWCarmila : Participation dans Galimmo SCA potentiellement..
27/6/202422:30PRNUSCarisma Therapeutics Announces Nomination of First In Vivo..
25/6/202413:30PRNUSCarisma Therapeutics Granted FDA Fast Track Designation for..
19/6/202401:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:32EDGAR2Form 8-K - Current report
14/6/202422:30EDGAR2Form 8-K - Current report
13/6/202422:30PRNUSCarisma Therapeutics Announces Adjournment of Annual Meeting..
Apertura: 0,38 Min: 0,38 Max: 0,4075
Chiusura: 0,388

La tua Cronologia

NASDAQ
CARM
Carisma Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network